 SAN DIEGO, Oct. 27, 2021 GLOBE NEWSWIRE -- Histogen Inc. NASDAQ: HSTO, a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function, today announced that Histogens financial results for the third quarter will be released after the close of market on Wednesday, November 10, 2021. 